iRadimed, which makes non-magnetic IV systems that are safe to use during MRI procedures, filed on Wednesday with the SEC to raise up to $12 million in an initial public offering. The Winter Park, FL-based company, which was founded in 1992 and booked $12 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol IRMD. Roth Capital is the sole bookrunner on the deal. No pricing terms were disclosed.
